BEIJING ENT Plans to Issue Corporate Bonds Up to RMB 10 Billion
Stock News
Jul 15
BEIJING ENT (HKEX: 00392) has announced its intention to issue corporate bonds within mainland China.
The company plans to issue the first tranche of its 2026 Science and Technology Innovation Corporate Bonds, which will be publicly offered to professional investors and listed on the Shanghai Stock Exchange.
The issuance size for this first tranche is set not to exceed RMB 10 billion.
The bond offering will consist of two series: Series One with a maturity of 5 years and Series Two with a maturity of 10 years.
The interest rates for both series will be determined through negotiations between the company and the lead underwriter, based on the book-building process.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.